Oral rhGH (somatotropin)

• Global sales of all injectable rhGH products >$1.7 billion/year
• Completed dosing of EMISPHEREŽ delivery agent and rhGH combination in first-in-man dose escalation study
• Preliminary data

Previous slide

Next slide

Back to first slide

View graphic version